Listen to the StoryA ‘Miracle’ HIV Drug May Not Reach the Women Who Need It Most
Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the twice-yearly injection into doubt.
Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the twice-yearly injection into doubt.
